Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians

International Journal of Cardiology

Volumn 191, Issue , 2015, Pages 20-24

  Wong, Christopher X ^a   Lee, Sarah W ^a   Gan, Siang Wei ^a   Mahajan, Rajiv ^a   Rangnekar, Geetanjali ^a   Pathak, Rajeev K ^a   Twomey, Darragh ^a   Schultz, Carlee ^a   Ganesan, Anand N ^a   Brooks, Anthony G ^a   Roberts Thomson, Kurt C ^a   Brown, Alex ^b   Lau, Dennis H ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Anticoagulation; Atrial fibrillation; Ethnicity; Indigenous; Stroke

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; COMORBIDITY; DRUG ABUSE; DRUG EFFECT; ETHNICITY; FEMALE; HIGH RISK PATIENT; HUMAN; INDIGENOUS AUSTRALIAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; AUSTRALIA; CLINICAL PRACTICE; DRUG MISUSE; ETHNIC GROUP; ETHNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION GROUP; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; AUSTRALIA; COMORBIDITY; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION GROUPS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTION DRUG OVERUSE; PREVALENCE; RISK FACTORS; STROKE;

EID: 84938828481     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.064     Document Type: Article

References (23)

1. M. Gattellari, C. Goumas, R. Aitken, and J.M. Worthington Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (a Program of Research Informing Stroke Management) Cerebrovasc. Dis. 32 2011 370 382
2. C.X. Wong, A.G. Brooks, D.P. Leong, K.C. Roberts-Thomson, and P. Sanders The increasing burden of atrial fibrillation compared to heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia Arch. Intern. Med. 172 2012 739 741
3. C.X. Wong, A.G. Brooks, D.H. Lau, and et al. Factors associated with the epidemic of hospitalizations due to atrial fibrillation Am. J. Cardiol. 110 2012 1496 1499
4. C.X. Wong, D.H. Lau, and P. Sanders Atrial fibrillation epidemic and hospitalizations: how to turn the rising tide? Circulation 129 2014 2361 2363
5. H.J. Lin, P.A. Wolf, M. Kelly-Hayes, and et al. Stroke severity in atrial fibrillation. The Framingham Study Stroke 27 1996 1760 1764
6. M.D. Ezekowitz, K.E. James, S.M. Nazarian, and et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Circulation 92 1995 2178 2182
7. D.H. Lau, J. Kalman, and P. Sanders Management of recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies Clin. Ther. 36 2014 1151 1159
8. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 2012 2298 2307
9. J.M. Katzenellenbogen, T. Vos, P. Somerford, S. Begg, J.B. Semmens, and J.P. Codde Burden of stroke in indigenous Western Australians: a study using data linkage Stroke 42 2011 1515 1521
10. A.G. Thrift, and N. Hayman Aboriginal and Torres Strait Islander peoples and the burden of stroke Int. J. Stroke 2 2007 57 59
11. C.X. Wong, A.G. Brooks, Y. Cheng, and et al. Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study BMJ Open 4 2014 e006242
12. M.F. Kilkenny, D.M. Harris, E.A. Ritchie, C. Price, D.A. Cadilhac, and National Stroke Foundation Hospital management and outcomes of stroke in Indigenous Australians: evidence from the 2009 Acute Care National Stroke Audit Int. J. Stroke 8 2013 164 171
13. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest J. 137 2010 263 272
14. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 130 2014 2071 2104
15. A.J. Camm, G.Y. Lip, R. De Caterina, and et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur. Heart J. 33 2012 2719 2747
16. A.K. Kakkar, I. Mueller, J.P. Bassand, and et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry PLoS One 8 2013 e63479
17. R. Nieuwlaat, A. Capucci, G.Y. Lip, and et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur. Heart J. 27 2006 3018 3026
18. P.J. Zimetbaum, A. Thosani, H.T. Yu, and et al. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am. J. Med. 123 2010 446 453
19. R. Nieuwlaat, S.B. Olsson, G.Y. Lip, and et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation Am. Heart J. 153 2007 1006 1012
20. L. Gorin, L. Fauchier, E. Nonin, B. Charbonnier, D. Babuty, and G.Y. Lip Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project Chest 140 2011 911 917
21. A.G. Thrift, D.A. Cadilhac, and S. Eades Excess risk of stroke in Australia's Aboriginal and Torres Strait Islander populations Stroke 42 2011 1501 1502
22. C.T. Ruff, R.P. Giugliano, E. Braunwald, and et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 2014 955 962
23. D. Deplanque, D. Leys, L. Parnetti, and et al. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study Br. J. Clin. Pharmacol. 57 2004 798 806